Advance Search
ZENG Ke, XIE Wenxian, YANG Jian, LI Xiaobin, LIU Yuejiang, CHEN Rong, DENG Kefei, WANG Tifen. Value of serum free prostate specific antigen in predicting prognosis in patients with benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 39-43. DOI: 10.7619/jcmp.20212093
Citation: ZENG Ke, XIE Wenxian, YANG Jian, LI Xiaobin, LIU Yuejiang, CHEN Rong, DENG Kefei, WANG Tifen. Value of serum free prostate specific antigen in predicting prognosis in patients with benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 39-43. DOI: 10.7619/jcmp.20212093
shu

Value of serum free prostate specific antigen in predicting prognosis in patients with benign prostatic hyperplasia

  • 1.

    Department of Urinary Surgery, Zigong City First People's Hospital of Sichuan Province, Zigong, Sichuan, 643000

  • 2.

    Department of Basic Medicine, Sichuan Vocational College of Health and Rehabilitation, Zigong, Sichuan, 643000

  • 3.

    Department of Anesthesiology, Neijiang City Second People's Hospital of Sichuan Province, Neijiang, Sichuan, 641000

More Information
  • Received Date: May 18, 2021
  • Available Online: March 28, 2022
  • Published Date: March 14, 2022
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the change of serum free prostate specific antigen (fPSA) in patients with benign prostatic hyperplasia (BPH) after transurethral enucleative resection of prostate (TUERP) and its relationships with prostate volume and prognosis.
      Methods  A total of 105 BPH patients with TUERP were divided into small volume group (n=49), medium volume group (n=36) and large volume group (n=20) according to preoperative prostate volume. The levels of serum fPSA were compared among three groups before operation and 1 day, 3 and 7 days after operation. The relationship between preoperative serum fPSA level and prostate volume was analyzed by Pearson method. The clinical materials and the level of serum fPSA at 7 days after operation were compared among BPH patients with different prognosis. Logistic regression analysis was used to explore the influencing factors of poor prognosis in BPH patients.
      Results  Before operation and 1 day after operation, the levels of serum fPSA in the small volume group, the medium volume group and the large volume group increased significantly (P < 0.05). Pearson analysis showed that there was a positive correlation between preoperative serum fPSA level and prostate volume in patients with BPH (r=0.598, P < 0.05). Compared with the good prognosis group (n=79), the high density lipoprotein cholesterol (HDL-C), blood glucose, serum fPSA level at 7 days after operation and the ratio of cases with hypertension in the poor prognosis group (n=26) were significantly higher (P < 0.05). Logistic regression analysis showed that HDL-C, blood glucose, hypertension and serum fPSA at 7 days after operation were the risk factors for the prognosis of BPH patients (P < 0.05).
      Conclusion  The serum fPSA level is highly expressed in BPH patients, which may be involved in the pathogenesis of BPH. The serum fPSA level at 7 days after operation can be used to evaluate the prognosis of BPH patients after TUERP.
    • FullText(HTML)
    • References (27)
  • [1]
    XUAN H N, HUY H D, BICH N N T, et al. Anatomical characteristics and variants of prostatic artery in patients of benign hyperplasia prostate by digital subtraction angiography[J]. Open Access Maced J Med Sci, 2019, 7(24): 4204-4208. doi: 10.3889/oamjms.2019.361
    [2]
    SPIRINA L V, KOVALEVA I V, USYNIN E A, et al. Progesterone receptor expression in the benign prostatic hyperplasia and prostate cancer tissues, relation with transcription, growth factors, hormone reception and components of the AKT/mTOR signaling pathway[J]. Asian Pac J Cancer Prev, 2020, 21(2): 423-429. doi: 10.31557/APJCP.2020.21.2.423
    [3]
    SCHÖB D S, REICHELT A C, GROSS A J, et al. Novel surgical techniques for treatment of benign prostatic hyperplasia[J]. Urologe A, 2020, 59(3): 347-358. doi: 10.1007/s00120-020-01149-1
    [4]
    石爱军, 江开航, 陈金叶, 等. 前列腺癌与前列腺增生的影像学诊断研究[J]. 局解手术学杂志, 2017, 26(9): 682-686. https://www.cnki.com.cn/Article/CJFDTOTAL-JJXZ201709015.htm
    [5]
    FU S, ZHANG X, NIU Y, et al. Prostate specific antigen, mean platelet volume, and platelet distribution width in combination to discriminate ProstateCancer from benign prostate hyperplasia[J]. Asian Pac J Cancer Prev, 2018, 19(3): 699-702.
    [6]
    张树江, 孙祖越. PSA与前列腺癌发展和转移相关性的研究进展[J]. 中华男科学杂志, 2018, 24(5): 457-461. https://www.cnki.com.cn/Article/CJFDTOTAL-NKXB201805018.htm
    [7]
    琚建军, 李云, 郑军荣, 等. 急性前列腺炎前列腺特异抗原和炎症指标的动态变化规律及意义[J]. 山西医药杂志, 2018, 47(23): 2789-2792. doi: 10.3969/j.issn.0253-9926.2018.23.005
    [8]
    李倩. 前列腺疾病患者游离前列腺特异性抗原比率检测结果分析[J]. 检验医学与临床, 2013, 10(24): 3341-3342. doi: 10.3969/j.issn.1672-9455.2013.24.047
    [9]
    何斌, 倪浩东, 唐庆生, 等. 经尿道前列腺等离子剜除术与经尿道前列腺电切术治疗前列腺增生临床疗效分析[J]. 中国现代手术学杂志, 2018, 22(1): 52-55. https://www.cnki.com.cn/Article/CJFDTOTAL-XDSS201801015.htm
    [10]
    高卫军, 成慧霞, 贺艳锋. 经尿道前列腺电切术与经尿道双极等离子电切术治疗良性前列腺增生的临床效果比较[J]. 西北国防医学杂志, 2018, 39(5): 332-334. https://www.cnki.com.cn/Article/CJFDTOTAL-XBGY201805018.htm
    [11]
    斯钦布和, 易发现, 王国强, 等. 经尿道前列腺剜除术治疗良性前列腺增生疗效观察[J]. 局解手术学杂志, 2019, 28(11): 891-895. https://www.cnki.com.cn/Article/CJFDTOTAL-JJXZ201911010.htm
    [12]
    YU Y, LOU G T, SHEN C, et al. Technical aspects of transurethral plasmakinetic enucleation and resection of the prostate for benign prostatic hyperplasia[J]. Minim Invasive Ther Allied Technol, 2017, 26(1): 44-50. doi: 10.1080/13645706.2016.1227851
    [13]
    《泌尿外科杂志(电子版)》编辑部. 《良性前列腺增生诊断治疗指南》解读: 治疗篇[J]. 泌尿外科杂志: 电子版, 2011, 3(4): 47-50. doi: 10.3969/j.issn.1674-7410.2011.04.017
    [14]
    范本, 齐范, 李文泽, 等. 湖南地区不同年龄、不同前列腺体积与血清中PSA及fPSA水平的相关性研究[J]. 实用预防医学, 2011, 18(11): 2034-2035. doi: 10.3969/j.issn.1006-3110.2011.11.002
    [15]
    HU J M, ZHANG L M, ZOU L J, et al. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: a population-based and single-institutional analysis[J]. Int J Urol, 2015, 22(12): 1138-1142. doi: 10.1111/iju.12914
    [16]
    GE Y Q, WANG Q D, SHAO W, et al. Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia[J]. J Cancer, 2020, 11(15): 4542-4549. doi: 10.7150/jca.45077
    [17]
    CHEN B, CAO D H, CHEN Z Y, et al. Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia[J]. Transl Androl Urol, 2020, 9(2): 322-331. doi: 10.21037/tau.2020.02.08
    [18]
    魏希锋. 经尿道等离子前列腺剜除术的研究进展[J]. 国际泌尿系统杂志, 2016(2): 248-250. doi: 10.3760/cma.j.issn.1673-4416.2016.02.027
    [19]
    王锋. 经尿道前列腺电切术与经尿道前列腺剜除术治疗大体积前列腺增生的安全性及有效性分析[J]. 实用医院临床杂志, 2018, 15(4): 199-201. doi: 10.3969/j.issn.1672-6170.2018.04.065
    [20]
    YVCEL C, BUDAK S, KISA E, et al. The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL[J]. Arch Ital UrolAndrol, 2018, 90(2): 104-106. doi: 10.4081/aiua.2018.2.104
    [21]
    SJOBERG D D, VICKERS A J, ASSEL M, et al. Twenty-year risk of prostate cancer death by midlife prostate-specific antigen and a panel of four kallikrein markers in a large population-based cohort of healthy men[J]. Eur Urol, 2018, 73(6): 941-948. doi: 10.1016/j.eururo.2018.02.016
    [22]
    李林, 阎成全, 翟玉普, 等. 血清总前列腺特异性抗原、血清游离前列腺特异性抗原与总特异性抗原的比值在前列腺癌中的诊断价值[J]. 中国煤炭工业医学杂志, 2017, 20(9): 1035-1038. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMGY201709011.htm
    [23]
    WANG X J, AN P, ZENG J L, et al. Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer[J]. Oncotarget, 2017, 8(11): 17862-17872. doi: 10.18632/oncotarget.14977
    [24]
    孟元, 卫中庆, 熊红兵, 等. 良性前列腺增生伴组织学炎症与PSA异常升高的相关性[J]. 江苏医药, 2013, 39(17): 2016-2018. https://www.cnki.com.cn/Article/CJFDTOTAL-YIYA201317012.htm
    [25]
    PEJCIC T P, TULIC C D Z, LALIC N V, et al. Urinary prostate-specific antigen: predictor of benign prostatic hyperplasia progression[J]. Can J Urol, 2013, 20(2): 6707-6713.
    [26]
    蒋团建, 黄仁胜. 血清PSA水平在良性前列腺增生患者术后预后判断中的价值[J]. 中国民康医学, 2019, 31(10): 124-126. doi: 10.3969/j.issn.1672-0369.2019.10.055
    [27]
    COBAN S, DOLUOGLU O G, KELES I, et al. Age and total and free prostate-specific antigen levels for predicting prostate volume in patients with benign prostatic hyperplasia[J]. Aging Male, 2016, 19(2): 124-127. doi: 10.3109/13685538.2015.1131260
    • Related Articles

  • Cited by

    Periodical cited type(4)

    1. 万建平，周强. 经直肠超声造影检查联合血清前列腺特异性抗原检测对前列腺癌的诊断及预后预测价值. 癌症进展. 2025(02): 236-239 .
    2. 王安勇，高余杰，黄学东，张衡，朱杰. 尿道前列腺切除术联合经尿道膀胱取石治疗老年前列腺增生伴膀胱结石的疗效及预后. 中国临床医生杂志. 2024(03): 290-294 .
    3. 潘宗森，王慧. 经尿道前列腺钬激光剜除术在大体积良性前列腺增生中的应用效果. 浙江创伤外科. 2024(03): 538-541 .
    4. 黄登辉，周广臣. 前列腺特异性抗原灰区患者前列腺穿刺活检结果的相关影响因素分析. 实用临床医药杂志. 2023(15): 77-81 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (219) PDF downloads (17) Cited by(4)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return